Rock Point Advisors’s Novo Nordisk NVO Stock Holding History
Bought
Maintained
Sold
Other funds holding NVO
DAM
F
Rock Point Advisors's NVO Position: Q1 2026 in Review
Rock Point Advisors reduced its Novo Nordisk (NVO) stake by 2.2% in Q1 2026, selling an estimated $7.11K and leaving 6,700 shares worth $246K. The position accounts for 0.07% of the portfolio, ranked #101.
Rock Point Advisors first reported a position in NVO in Q4 2019 and has held it in 26 quarters since. The position peaked at $1.01M in Q2 2024. 1,271 funds tracked by Wall St. Rank hold NVO as of Q1 2026.
- Rock Point Advisors held 6,700 shares of Novo Nordisk worth $246K as of Q1 2026.
- Rock Point Advisors sold 150 Novo Nordisk shares in Q1 2026, an estimated $7.11K.
- Novo Nordisk made up 0.07% of Rock Point Advisors's portfolio in Q1 2026, its #101 holding.
- Rock Point Advisors first reported a position in Novo Nordisk in Q4 2019 and has held it in 26 quarters since.
- Rock Point Advisors's Novo Nordisk position peaked at $1.01M in Q2 2024.
- 1,271 funds tracked by Wall St. Rank held Novo Nordisk as of Q1 2026.
Based on Rock Point Advisors's 13F filing for Q1 2026, filed 14 May 2026.